Please ensure Javascript is enabled for purposes of website accessibility

Why Endo Stock Is Crashing Today

By Keith Speights – Aug 20, 2021 at 11:19AM

Key Points

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The drugmaker could be evaluating financial restructuring options.

What happened

Shares of Endo International (ENDP 1.39%) were crashing 28.6% lower as of 11:07 a.m. EDT on Friday. The big decline came after The Wall Street Journal reported that the drugmaker has engaged Alvarez & Marsal to look into a potential financial restructuring. 

So what

The report of a potential restructuring is only the latest of woes Endo has faced related to a flood of opioid-related lawsuits. The pharmaceutical stock had already plunged 66% year to date before today's drop.

Pill bottles on their sides with pills spilled out.

Image source: Getty Images.

Endo hasn't confirmed that it hired a financial restructuring advisor. However, The Wall Street Journal stated that "people familiar with the matter" said the drugmaker brought in Alvarez & Marsal to explore options for reducing the company's litigation-related liabilities and its debt load of more than $8 billion.

Financial restructuring can be achieved in several ways. Sometimes, parts of the business are sold off. However, some companies end up filing for bankruptcy and reorganizing. 

Now what

It remains to be seen if Endo is indeed considering undergoing a financial restructuring. However, this stock has been one to stay away from for a long time. Today's news underscores why that's a prudent move.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Stocks Mentioned

Endo International Stock Quote
Endo International
ENDP
$0.09 (1.39%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.